Kraig Biocraft Laboratories, Inc – ‘10-K’ for 12/31/19 – ‘EX-21.1’

On:  Friday, 3/27/20, at 4:31pm ET   ·   For:  12/31/19   ·   Accession #:  1493152-20-4918   ·   File #:  333-146316

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    608K 
 2: EX-10.16    Material Contract                                   HTML     65K 
 3: EX-21.1     Subsidiaries List                                   HTML     18K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
29: R1          Document Entity Information                         HTML     55K 
61: R2          Consolidated Balance Sheets                         HTML    100K 
44: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
21: R4          Consolidated Statements of Operations               HTML     70K 
30: R5          Consolidated Statements of Cash Flows               HTML     99K 
62: R6          Consolidated Statement of Changes in Stockholders   HTML     62K 
                Deficit (Unaudited)                                              
45: R7          Consolidated Statement of Changes in Stockholders   HTML     23K 
                Deficit (Unaudited) (Parenthetical)                              
22: R8          Summary of Significant Accounting Policies and      HTML     73K 
                Organization                                                     
28: R9          Going Concern                                       HTML     23K 
49: R10         Equipment                                           HTML     26K 
55: R11         Right to Use Assets and Lease Liability             HTML     38K 
36: R12         Accrued Interest - Related Party                    HTML     25K 
15: R13         Note Payable                                        HTML     23K 
48: R14         Stockholders' Deficit                               HTML     80K 
54: R15         Commitments and Contingencies                       HTML     52K 
35: R16         Related Party Transactions                          HTML     42K 
14: R17         Subsequent Events                                   HTML     25K 
50: R18         Summary of Significant Accounting Policies and      HTML    110K 
                Organization (Policies)                                          
53: R19         Summary of Significant Accounting Policies and      HTML     52K 
                Organization (Tables)                                            
33: R20         Equipment (Tables)                                  HTML     26K 
24: R21         Right to Use Assets and Lease Liabilitity (Tables)  HTML     30K 
43: R22         Stockholders' Deficit (Tables)                      HTML     73K 
60: R23         Summary of Significant Accounting Policies and      HTML     36K 
                Organization (Details Narrative))                                
32: R24         Summary of Significant Accounting Policies and      HTML     25K 
                Organization - Schedule of Antidilutive Securities               
                of Earnings Per Share (Details)                                  
23: R25         Summary of Significant Accounting Policies and      HTML     22K 
                Organization - Schedule of Antidilutive Securities               
                of Earnings Per Share (Details) (Parenthetical)                  
42: R26         Summary of Significant Accounting Policies and      HTML     33K 
                Organization - Schedule of Deferred Tax Assets and               
                Liabilities (Details)                                            
59: R27         Summary of Significant Accounting Policies and      HTML     23K 
                Organization - Schedule of Deferred Tax Assets and               
                Liabilities (Details) (Parenthetical)                            
31: R28         Summary of Significant Accounting Policies and      HTML     30K 
                Organization - Schedule of Components of Deferred                
                Income Taxes (Details)                                           
25: R29         Summary of Significant Accounting Policies and      HTML     25K 
                Organization - Schedule of Fair Value of Financial               
                Instruments (Details)                                            
17: R30         Summary of Significant Accounting Policies and      HTML     27K 
                Organization - Schedule of Concentration of Credit               
                Risk (Details)                                                   
37: R31         Going Concern (Details Narrative)                   HTML     29K 
51: R32         Equipment (Details Narrative)                       HTML     22K 
46: R33         Equipment - Schedule of Property and Equipment      HTML     35K 
                (Details)                                                        
18: R34         Right to Use Assets and Lease Liability - (Details  HTML     59K 
                Narrative)                                                       
38: R35         Right to Use Assets and Lease Liability - Schedule  HTML     26K 
                of Right Use of Assets (Details)                                 
52: R36         Right to Use Assets and Lease Liability - Schedule  HTML     30K 
                of Lease Liability (Details)                                     
47: R37         Right to Use Assets and Lease Liability - Schedule  HTML     25K 
                of Lease Cost (Details)                                          
16: R38         Accrued Interest - Related Party (Details           HTML     40K 
                Narrative)                                                       
39: R39         Note Payable (Details Narrative)                    HTML     38K 
19: R40         Stockholders' Deficit (Details Narrative)           HTML    168K 
26: R41         Stockholders' Deficit - Schedule of Option          HTML     69K 
                Assumption (Details)                                             
57: R42         Stockholders' Deficit - Schedule of Warrants        HTML     49K 
                Activity (Details)                                               
40: R43         Stockholders' Deficit - Schedule of Warrants        HTML     53K 
                Outstanding (Details)                                            
20: R44         Commitments and Contingencies (Details Narrative)   HTML    284K 
27: R45         Related Party Transactions (Details Narrative)      HTML    261K 
58: R46         Subsequent Events (Details Narrative)               HTML     32K 
41: XML         IDEA XML File -- Filing Summary                      XML    106K 
56: EXCEL       IDEA Workbook of Financial Reports                  XLSX     69K 
 8: EX-101.INS  XBRL Instance -- kblb-20191231                       XML   1.25M 
10: EX-101.CAL  XBRL Calculations -- kblb-20191231_cal               XML    122K 
11: EX-101.DEF  XBRL Definitions -- kblb-20191231_def                XML    527K 
12: EX-101.LAB  XBRL Labels -- kblb-20191231_lab                     XML    868K 
13: EX-101.PRE  XBRL Presentations -- kblb-20191231_pre              XML    678K 
 9: EX-101.SCH  XBRL Schema -- kblb-20191231                         XSD    159K 
34: ZIP         XBRL Zipped Folder -- 0001493152-20-004918-xbrl      Zip    112K 

‘EX-21.1’   —   Subsidiaries List

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

26 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/24  Kraig Biocraft Laboratories, Inc. 10-K       12/31/23   75:8.1M                                   M2 Compliance LLC/FA
11/22/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. POS AM                67:13M                                    M2 Compliance LLC/FA
 9/01/23  Kraig Biocraft Laboratories, Inc. S-1/A                 67:13M                                    M2 Compliance LLC/FA
 6/06/23  Kraig Biocraft Laboratories, Inc. S-1/A                 66:13M                                    M2 Compliance LLC/FA
 5/09/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/27/23  Kraig Biocraft Laboratories, Inc. S-1/A                  1:2.2M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.9M                                   M2 Compliance LLC/FA
 4/14/23  Kraig Biocraft Laboratories, Inc. POS AM                65:9.1M                                   M2 Compliance LLC/FA
 3/29/23  Kraig Biocraft Laboratories, Inc. 10-K       12/31/22   70:8.7M                                   M2 Compliance LLC/FA
12/01/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:14M                                    M2 Compliance LLC/FA
 5/25/22  Kraig Biocraft Laboratories, Inc. S-1/A                 64:12M                                    M2 Compliance LLC/FA
 4/14/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:10M                                    M2 Compliance LLC/FA
 3/23/22  Kraig Biocraft Laboratories, Inc. S-1/A                 65:9.7M                                   M2 Compliance LLC/FA
 3/16/22  Kraig Biocraft Laboratories, Inc. 10-K       12/31/21   69:9.6M                                   M2 Compliance LLC/FA
 2/10/22  Kraig Biocraft Laboratories, Inc. S-1                   67:13M                                    M2 Compliance LLC/FA
12/03/21  Kraig Biocraft Laboratories, Inc. S-1/A                 64:13M                                    M2 Compliance LLC/FA
 8/25/21  Kraig Biocraft Laboratories, Inc. S-1/A                 63:12M                                    M2 Compliance LLC/FA
 5/26/21  Kraig Biocraft Laboratories, Inc. S-1/A                 86:9.3M                                   M2 Compliance LLC/FA
 4/15/21  Kraig Biocraft Laboratories, Inc. S-1/A                  1:74K                                    M2 Compliance LLC/FA
 4/14/21  Kraig Biocraft Laboratories, Inc. S-1/A                  2:161K                                   M2 Compliance LLC/FA
 4/05/21  Kraig Biocraft Laboratories, Inc. S-1                   63:6M                                     M2 Compliance LLC/FA
 3/12/21  Kraig Biocraft Laboratories, Inc. 10-K       12/31/20   67:5.7M                                   M2 Compliance LLC/FA
 2/18/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
 2/08/21  Kraig Biocraft Laboratories, Inc. S-1/A                 78:9.1M                                   M2 Compliance LLC/FA
 8/24/20  Kraig Biocraft Laboratories, Inc. S-1/A                 68:7.8M                                   M2 Compliance LLC/FA